Provided by Tiger Trade Technology Pte. Ltd.

Tredegar

7.69
-0.1100-1.41%
Post-market: 7.690.00000.00%19:30 EDT
Volume:120.85K
Turnover:929.21K
Market Cap:268.46M
PE:8.03
High:7.80
Open:7.74
Low:7.64
Close:7.80
52wk High:10.53
52wk Low:6.25
Shares:34.91M
Float Shares:28.20M
Volume Ratio:0.91
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9572
EPS(LYR):0.9604
ROE:15.47%
ROA:6.50%
PB:1.17
PE(LYR):8.01

Loading ...

TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial

GlobeNewswire
·
May 27

Tredegar names Susan Sweeney as chief human resources officer effective June 1, 2026

Reuters
·
May 27

Tredegar Corporation Announces Susan Sweeney Joins Company as Vice President and Chief Human Resources Officer

THOMSON REUTERS
·
May 27

Tredegar 10% owner James T. Gottwald disposes of 141 shares for $1,128

Reuters
·
May 27

TG Therapeutics Announces Data Presentations for BRIUMVI® at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting

GlobeNewswire
·
May 26

How Investors May Respond To TG Therapeutics (TGTX) Boosting 2026 Guidance On Stronger Briumvi Sales

Simply Wall St.
·
May 24

Tredegar CEO Arijit DasGupta acquires $7,550 in common shares

Reuters
·
May 22

TG Therapeutics Raises 2026 Outlook As Briumvi Drives Concentrated Growth

Simply Wall St.
·
May 22

Insider Shake-Up at Tredegar: Director’s Stock Sale Draws Investor Attention

TIPRANKS
·
May 21

Tredegar director Carl E. Tack III disposes of $42,457 common shares

Reuters
·
May 21

TG-17 Showcases Strategy at LD Micro Invitational

TIPRANKS
·
May 19

Tredegar 10% owner James T. Gottwald sells 11,934 shares for $97,085.74

Reuters
·
May 19

Tredegar 10% owner John D. Gottwald sells 30,221 shares for $258,740

Reuters
·
May 15

TG-17 CEO Featured Live on Big Biz Show

TIPRANKS
·
May 14

Tredegar Shareholders Show Mixed Support at 2026 Meeting

TIPRANKS
·
May 14

Tredegar files Form 3 for director Cynthia Boiter as beneficial owner

Reuters
·
May 14

Tredegar shareholders elect directors at annual meeting

Reuters
·
May 14

A Look At TG Therapeutics (TGTX) Valuation After Record Q1 Revenue And Higher 2026 Guidance

Simply Wall St.
·
May 10

Tredegar reports Q1 EPS 15c vs. 2c last year

TIPRANKS
·
May 09

Tredegar publishes presentation for 2026 annual shareholder meeting

Reuters
·
May 08